Cambridge Investment Research Advisors
TMDI

Cambridge Investment Research Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,381
Closed -$24K – 2429
2019
Q2 		$24K Buy
+10,381
New +$26K ﹤0.01% 2178

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SHA
Seneca House Advisors Richmond, Virginia $283M AUM 22.4% 1-Year Est. Return

Cambridge Investment Research Advisors's TMDI Position: Q3 2019 in Review

Cambridge Investment Research Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q3 2019, closing a stake of 10,381 shares — an estimated $24K sold.

Cambridge Investment Research Advisors first reported a position in TMDI in Q2 2019 and held it in 1 quarter. The position peaked at $24K in Q2 2019. 42 funds tracked by Wall St. Rank hold TMDI as of Q3 2019.

  • Cambridge Investment Research Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,381 Titan Medical Inc. Ordinary Shares shares in Q3 2019, an estimated $24K.
  • Cambridge Investment Research Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2019 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Titan Medical Inc. Ordinary Shares position peaked at $24K in Q2 2019.
  • 42 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q3 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.